FDA Approves Foundayo, a Wegovy Alternative GLP-1 Pill for Weight Loss

**New Weight Loss Option Now Available** We are pleased to announce that a new once-daily GLP-1 pill has been approved by the FDA for weight loss.

**New Weight Loss Option Now Available** We are pleased to announce that a new once-daily GLP-1 pill has been approved by the FDA for weight loss. This medication, called Foundayo, is manufactured by Eli Lilly and is designed to be taken in conjunction with a healthy diet and regular exercise.

Foundayo is an oral GLP-1 receptor agonist that works by mimicking the action of a natural hormone in the body, helping to reduce hunger and increase feelings of fullness. It is available in pill form and can be taken with or without food.

**How Foundayo Works**

The medication is taken once daily, with the starting dosage being 0.8 milligrams (mg). The dosage may be increased based on treatment response and tolerability, up to a maximum of 17.2 mg per day. Foundayo has been shown to be effective in reducing excess body weight and maintaining long-term weight reduction in adults with obesity or overweight with at least one weight-related comorbid condition.

**Availability and Cost**

Foundayo is now available through LillyDirect, with prescriptions accepted immediately and shipping beginning April 6. Broad availability through U.S. retail pharmacies and telehealth providers is expected soon. Eligible individuals with commercial insurance may pay as little as $25 per month for the drug, while those opting for self-pay can purchase Foundayo for $149 per month for the lowest dose.

**Expert Reaction**

Experts say that the approval of Foundayo is a positive step toward managing obesity. "It's a significant milestone to have another GLP-1 tablet," said Pouya Shafipour, MD, a family and obesity medicine physician at Providence Saint John’s Health Center in Santa Monica, CA. Zhaoping Li, MD, the chief of the Division of Clinical Nutrition at UCLA Health and director of the UCLA Center for Human Nutrition in Los Angeles, also welcomed the news, stating that "it is great to have new tools added to our toolbox to deal with obesity."

**Fast Approval Process**

The Foundayo approval was conducted under the FDA’s National Priority Voucher pilot program, which is designed to expedite the approval of medications needed to address national health priorities. The application was approved 50 days after submission.

Learn more about hair transplant at Rubenhair clinic.